Skip to main content

Advertisement

SpringerLink
Log in

Serum interferon and clinical manifestations of infection with human T-lymphotropic virus type III

  • Published:
Medical Microbiology and Immunology Aims and scope Submit manuscript

Abstract

Sera from 32 homosexual men were studied for the presence of antibodies against humanT-lymphotropic virus type III (HTLV III) and acidlabile interferon (IFN) alpha. Infection with HTLV III was found to be associated with the presence of serum IFN. IFN was detected in 74% of sera from male homosexuals with HTLV III antibody, but in only 6% of sera from antibody-negative individuals. More than 80% of sera from HTLV III-infected patients with the acquired immune deficiency syndrome (AIDS) or pre-AIDS conditions (generalized lymphadenopathy or the AIDS-related complex) were positive for IFN, while IFN was not present in sera from healthy homosexual men with HTLV III antibody. In conclusion, the presence of serum IFN may be predictive of the development of AIDS or pre-AIDS conditions in male homosexuals exposed to HTLV III.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abb J, Abb H, Deinhardt F (1983) Characterization of human interferon gamma producing leukocytes with monoclonal antileukocyte antibodies. Med Microbiol Immunol 171: 215–223

    Article  PubMed  Google Scholar 

  2. Abb J, Kochen M, Deinhardt F (1984) Interferon production in male homosexuals with the acquired immune deficiency syndrome (AIDS) or generalized lymphadenopathy. Infection 12: 240–242

    Article  PubMed  Google Scholar 

  3. Abb J (1985) Comparative determination of serum interferon alpha in patients at risk for AIDS by bioassay and radioimmunoassay. Proc. Int. Symp. Impact of Biotechnology on Diagnostics (in press)

  4. Barre-Sinoussi F, Chermann J C, Rey F, Nugeyre M T, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vezinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L (1983) Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220: 868–871

    PubMed  Google Scholar 

  5. Broder S, Gallo R C (1984) A pathogenic retrovirus (HTLV III) linked to AIDS. N Engl J Med 311: 1292–1297

    PubMed  Google Scholar 

  6. Buimovici-Klein E, Lange M, Klein R J, Cooper L Z, Grieco M H (1983) Is presence of interferon predictive for AIDS? Lancet II: 344

    Article  Google Scholar 

  7. Centers for Disease Control (1982) Updata on acguired immune deficiency syndrome (AIDS)-United States. Morbid Mortal Weekly Rep 31: 507–514

    Google Scholar 

  8. De Stefano E, Friedman R M, Friedman-Kien A E, Goedert J J, Henriksen D, Preble O T, Sonnabend J, Vilcek J (1982) Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy. J Infect Dis. 146:451–455

    PubMed  Google Scholar 

  9. Eyster E M, Goedert J J, Poon M C, Preble O T (1983) Acid-labile alpha interferon. A possible preclinical marker for the acquired immune deficiency syndrome in hemophilia. N Engl J Med. 309: 583–586

    PubMed  Google Scholar 

  10. Gallo R C, Salahudding S Z, Popovic M, Shearer G M, Kaplan M, Haynes B F, Palker T J, Redfield R, Oleske J, Safai B, White G, Foster P, Markham P D (1984) Frequent detection and isolation of cytopathic retroviruses (HTLV III) from patients with AIDS and at risk for AIDS. Science 224: 500–503

    PubMed  Google Scholar 

  11. Ho D D, Hartshorn K L, Rota T L, Andrews C A, Kaplan J C, Schooley R T, Hirsch M S (1985) Recombinant human interferon alpha-A suppresses HTLV III replication in vitro. Lancet I: 602–604

    Article  Google Scholar 

  12. Lopez C, Fitzgerald P A, Siegal F P (1983) Severe acquired immune deficiency syndrome in male homosexuals: Diminished capacity to make interferon alpha in vitro associated with severe opportunistic infections. J Infect Dis 148: 962–966

    PubMed  Google Scholar 

  13. Moffat E H, Bloom A L, Mortimer P P (1985) HTLV III antibody status and immunological abnormalities in hemophilic patients. Lancet I: 935

    Article  Google Scholar 

  14. Safai B, Sarngadharan M G, Groopman J E, Arnett K, Popovic M, Sliski A, Schüpbach J, Gallo R C (1984) Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immune deficiency syndrome. Lancet I: 1438–1440

    Article  Google Scholar 

  15. Sarngadharan M G, Popovic M, Bruch L, Schüpbach J, Gallo R C (1984) Antibodies reactive with human T-lymphotropic retroviruses (HTLV III) in the serum of patients with AIDS. Science 224: 506–508

    PubMed  Google Scholar 

  16. Schneider J, Bayer H, Bienzle U, Wernet P, Hunsmann G (1985) Antibodies to HTLV III in German blood donors. Lancet I: 275–276

    Article  Google Scholar 

  17. Weiss S H, Goedert J J, Sarngadharan M G, Bodner A J, Gallo R C, and Blattner W A (1985) Screening test for HTLV III (AIDS agent) antibodies. Specificity, sensitivity, and applications. J Am Med Ass 253: 221–225

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Städtisches Klinikum Nürnberg, Serologisches Institut, Flurstr. 17, D-8500, Nürnberg, Federal Republic of Germany

    J. Abb

Authors
  1. J. Abb
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abb, J. Serum interferon and clinical manifestations of infection with human T-lymphotropic virus type III. Med Microbiol Immunol 174, 205–210 (1985). https://doi.org/10.1007/BF02123697

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02123697

Keywords

Search

Navigation